Feb 16 (Reuters) - Biocon (BION.NS), opens new tab is aiming for high-double-digit percentage revenue growth as the Indian pharmaceutical firm prepares to launch generic versions of weight-loss drugs ...

C+A Global has just launched the HP FilmScan 7" Touch Screen Film Scanner – bringing a new supersized screen to our top film scanner for ease of use. Following on from the popular HP FilmScan 5" Touch ...

Abstract: Accurate measurement of bladder volume is critical for the effective management of urinary diseases. Among the available modalities, ultrasound imaging is favored due to its ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

On December 13, 2025, Biocon Biologics Ltd. (“Biocon”) and Regeneron Pharmaceuticals, Inc. (“Regeneron”) entered into a license and settlement agreement to dismiss all pending claims in the parties’ ...

Biocon Biologics Ltd obtains full exclusive global rights for Hulio, a biosimilar Adalimumab, from Fujifilm Kyowa Kirin Biologics. The deal grants Biocon control over manufacturing and ...

The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said. The shares are subject to a six-month lock up period. Transaction value will be subject to related ...

Learning the symptoms of bladder cancer may help you identify this cancer in its earliest stages before it grows or spreads beyond your bladder. While other conditions may also cause similar symptoms, ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...

Squamous cell carcinoma of the bladder is rare, accounting for 2% to 5% of bladder cancers in the U.S., and is linked to chronic bladder irritation. Diagnosis involves cystoscopy, biopsy, and imaging ...